DICYNONE

This brand name is authorized in Cyprus, Ecuador, Estonia, France, Lithuania, Mexico, Singapore, Tunisia

Active ingredients

The drug DICYNONE contains one active pharmaceutical ingredient (API):

1 Etamsylate UNII 24YL531VOH - ETHAMSYLATE

Etamsylate is a synthetic antihaemorrhagic and angioprotective drug acting on the first step of haemostasis (endothelium-platelet interaction). By improving platelet adhesiveness and restoring capillary resistance, it is able to reduce bleeding time and blood losses. Read about Etamsylate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DICYNONE 500 Tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC
DICYNONE 250 Solution for injection	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BX01	Etamsylate	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BX Other systemic hemostatics
Discover more medicines within B02BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2661-MEE-0417, 29189-02-10
Country: EE	Ravimiamet	Identifier(s): 1092147
Country: FR	Base de données publique des médicaments	Identifier(s): 62904574, 63619119, 65312567
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1006934, 1007139
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 021M2000, 142M99, 212M
Country: SG	Health Sciences Authority	Identifier(s): 00204P, 00279P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 20723011, 20723012, 20723013